Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
Anemia is common in cancer patients and impacts on quality of life and prognosis. It is typically multifactorial, often involving different pathophysiological mechanisms, making treatment a difficult task. In patients undergoing active anticancer treatments like chemotherapy, decreased red blood cel...
Main Authors: | Claudia Bozzini, Fabiana Busti, Giacomo Marchi, Alice Vianello, Claudio Cerchione, Giovanni Martinelli, Domenico Girelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1380358/full |
Similar Items
-
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis
by: Giacomo Marchi, et al.
Published: (2019-04-01) -
RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway
by: Gianluca De Rosa, et al.
Published: (2020-08-01) -
The Relationship Between Some Anemia Parameters and Hepcidin Level in Anaplasma phagocytophilum Seropositive Dogs
by: Menekşe Deni̇z, et al.
Published: (2020-12-01) -
Anemia in the Elderly
by: Domenico Girelli, et al.
Published: (2018-06-01) -
Role of hepcidin in the development of anemia in patients with rheumatoid arthritis
by: Elena Andreyevna Galushko, et al.
Published: (2012-06-01)